Reaction
Blood Alkaline Phosphatase Abnormal reporting signals
As of the last recalculation, Blood Alkaline Phosphatase Abnormal appears in 885 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is ASFOTASE ALFA (PRR 132.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Asfotase Alfa | 53 | 132.3 | 133.0 |
| Ursosiol | 77 | 101.9 | 102.3 |
| Ursodiol | 81 | 96.2 | 96.5 |
| Itraconazole | 28 | 58.2 | 58.3 |
| Fluticasone Furoate | 24 | 47.9 | 48.0 |
| Trifluridine And Tipiracil | 15 | 33.4 | 33.5 |
| Brentuximab Vedotin | 11 | 25.5 | 25.6 |
| Anastrozole Tablets | 22 | 24.7 | 24.7 |
| Sennosides 8.6 Mg Tablets | 21 | 24.1 | 24.1 |
| Senna | 21 | 24.0 | 24.0 |
| Senna Leaf | 22 | 23.0 | 23.0 |
| Fulvestrant | 24 | 17.5 | 17.5 |
| Sennosides | 21 | 16.9 | 16.9 |
| Anastrozole | 24 | 15.8 | 15.8 |
| Dexlansoprazole | 27 | 15.7 | 15.7 |
| Ribociclib | 20 | 15.2 | 15.2 |
| Fenofibrate | 22 | 14.9 | 14.9 |
| Dapagliflozin | 19 | 14.5 | 14.5 |
| Lopinavir And Ritonavir | 8 | 14.0 | 14.0 |
| Mepolizumab | 26 | 12.6 | 12.7 |
| Erlotinib Hydrochloride | 6 | 11.3 | 11.4 |
| Avapritinib | 5 | 9.8 | 9.8 |
| Erlotinib | 4 | 9.8 | 9.8 |
| Oxaliplatin | 27 | 8.8 | 8.8 |
| Temozolomide | 7 | 7.9 | 7.9 |
| Irinotecan Hydrochloride | 4 | 7.3 | 7.3 |
| Osimertinib | 7 | 5.2 | 5.2 |
| Abaloparatide | 6 | 4.8 | 4.8 |
| Tapentadol Hydrochloride | 6 | 4.2 | 4.2 |